Does controlled ovarian stimulation (COS) in assisted reproductive technologies with recombined human FSH (r-hFSH) need the use of human menopausal gonadotropin (HMG)?
K. Mahmoud, F. Zhioua, M.H. Ben Aribia, F. Meherzi, J. Nemsia, M. ElouakdiVolume:
76
Year:
2001
Language:
english
DOI:
10.1016/s0015-0282(01)02700-5
File:
PDF, 35 KB
english, 2001